• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性患者中睾酮与心肌梗死及冠状动脉疾病严重程度的关联

Association of testosterone with myocardial infarction and severity of coronary artery disease among male patients.

作者信息

Tang Lujing, Chen Mengsha, Li Jiahao, Xu Xiaodong, Pu Xiangyuan

机构信息

Department of Gastroenterology, The Children's Hospital Zhejiang University School of Medicine, China.

School of Public Health, Zhejiang University School of Medicine, China.

出版信息

Int J Cardiol Cardiovasc Risk Prev. 2024 May 7;21:200281. doi: 10.1016/j.ijcrp.2024.200281. eCollection 2024 Jun.

DOI:10.1016/j.ijcrp.2024.200281
PMID:38779505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11109021/
Abstract

BACKGROUND

Coronary heart disease (CHD) remains a leading cause of morbidity and mortality, particularly in aging populations. Men typically exhibit higher rates of CHD compared to women, with testosterone levels inversely associated with cardiovascular risk. This study investigates the relationship between testosterone levels and angiographically confirmed CHD, disease severity, and myocardial infarction (MI) among CHD cases.

METHODS

A cohort of 1724 male patients undergoing diagnostic or interventional coronary angiography was examined. Demographic, clinical, and biochemical data were collected, including serum total testosterone levels. The severity of CHD was assessed using the Gensini score, and MI cases were diagnosed according to World Health Organization criteria.

RESULTS

Results revealed significant differences in testosterone levels among CHD subtypes, particularly between MI and unstable angina/stable angina groups (p < 0.001). Testosterone levels were inversely correlated with CHD severity, as evidenced by the Gensini score (Pearson coefficient = -0.062, P = 0.004). Cross-validation random forest analysis demonstrated the significant contribution of testosterone to CHD severity discrimination (p < 0.05).

CONCLUSIONS

There is an association between testosterone and a predisposition to severe CAD indicated by Gensini score and myocardial infarction.

摘要

背景

冠心病(CHD)仍然是发病和死亡的主要原因,尤其是在老年人群中。与女性相比,男性通常表现出更高的冠心病发病率,睾酮水平与心血管风险呈负相关。本研究调查了冠心病患者中睾酮水平与血管造影确诊的冠心病、疾病严重程度及心肌梗死(MI)之间的关系。

方法

对1724例接受诊断性或介入性冠状动脉造影的男性患者进行了研究。收集了人口统计学、临床和生化数据,包括血清总睾酮水平。使用Gensini评分评估冠心病的严重程度,并根据世界卫生组织标准诊断心肌梗死病例。

结果

结果显示,冠心病各亚型之间的睾酮水平存在显著差异,尤其是心肌梗死组与不稳定型心绞痛/稳定型心绞痛组之间(p < 0.001)。睾酮水平与冠心病严重程度呈负相关,Gensini评分证明了这一点(Pearson系数 = -0.062,P = 0.004)。交叉验证随机森林分析表明,睾酮对冠心病严重程度的鉴别有显著贡献(p < 0.05)。

结论

睾酮与Gensini评分和心肌梗死所表明的严重冠状动脉疾病易感性之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/14c503431ecf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/fb6dca09501a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/828d4be327c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/5250b2e4652a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/14c503431ecf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/fb6dca09501a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/828d4be327c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/5250b2e4652a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3021/11109021/14c503431ecf/fx1.jpg

相似文献

1
Association of testosterone with myocardial infarction and severity of coronary artery disease among male patients.男性患者中睾酮与心肌梗死及冠状动脉疾病严重程度的关联
Int J Cardiol Cardiovasc Risk Prev. 2024 May 7;21:200281. doi: 10.1016/j.ijcrp.2024.200281. eCollection 2024 Jun.
2
Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者炎症因子的变化。
Chin Med J (Engl). 2018 Jun 20;131(12):1444-1449. doi: 10.4103/0366-6999.233953.
3
Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.血小板糖蛋白IIIa PlA1/A2基因多态性与冠状动脉疾病相关,但与低风险患者的非致死性心肌梗死无关。
Thromb Haemost. 1998 Aug;80(2):214-7.
4
Low testosterone level in middle-aged male patients with coronary artery disease.中年男性冠心病患者的低睾酮水平。
Eur J Intern Med. 2011 Dec;22(6):e133-6. doi: 10.1016/j.ejim.2011.08.016. Epub 2011 Sep 1.
5
Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease.血清同型半胱氨酸(Hcy)、高密度脂蛋白胆固醇(HDL-C)、内脂素(vaspin)和内脏脂肪素(visfatin)水平及其在老年不同类型冠心病患者中的临床意义。
Ann Palliat Med. 2021 May;10(5):5679-5686. doi: 10.21037/apm-21-1001.
6
Changes in plasma levels of RIPK1, RIPK3, and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value.冠状动脉粥样硬化性心脏病患者血浆中RIPK1、RIPK3和MLKL水平的变化及其临床预测价值。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(9):1096-1103. doi: 10.11817/j.issn.1672-7347.2020.200026.
7
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
8
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.新型抗炎因子——乳脂肪球表皮生长因子 8 在冠心病患者中的作用。
Atherosclerosis. 2014 Apr;233(2):661-665. doi: 10.1016/j.atherosclerosis.2014.01.013. Epub 2014 Jan 22.
9
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
10
The application of Gensini score and IL-1ra in assessing the condition and prognosis of patients with coronary artery disease.Gensini评分和白细胞介素-1受体拮抗剂在评估冠心病患者病情及预后中的应用。
Am J Transl Res. 2021 Sep 15;13(9):10421-10427. eCollection 2021.

引用本文的文献

1
Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity.当前治疗心力衰竭的抗炎策略:从固有免疫到适应性免疫。
Pharmacol Res. 2025 Jun;216:107761. doi: 10.1016/j.phrs.2025.107761. Epub 2025 May 8.

本文引用的文献

1
Cardiovascular Safety of Testosterone-Replacement Therapy.睾酮替代疗法的心血管安全性。
N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16.
2
Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study.循环雄激素浓度与老年男性心力衰竭事件风险:心血管健康研究。
J Am Heart Assoc. 2022 Nov;11(21):e026953. doi: 10.1161/JAHA.122.026953. Epub 2022 Oct 26.
3
Testosterone, Hypogonadism, and Heart Failure.睾酮、性腺功能减退症与心力衰竭。
Circ Heart Fail. 2022 Jul;15(7):e008755. doi: 10.1161/CIRCHEARTFAILURE.121.008755. Epub 2022 Apr 8.
4
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.长期睾酮治疗对性腺功能减退症男性心血管结局的影响:TRAVERSE 研究的原理和设计。
Am Heart J. 2022 Mar;245:41-50. doi: 10.1016/j.ahj.2021.11.016. Epub 2021 Dec 4.
5
Testosterone therapy and cardiovascular diseases.睾酮治疗与心血管疾病。
Cardiovasc Res. 2022 Jul 20;118(9):2039-2057. doi: 10.1093/cvr/cvab241.
6
Low free testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors.低游离睾酮水平可预测日本有冠心病风险因素男性的心血管事件。
Aging Male. 2021 Dec;24(1):8-14. doi: 10.1080/13685538.2021.1920912.
7
Prognostic value of total testosterone levels in patients with acute coronary syndromes.总睾酮水平对急性冠状动脉综合征患者的预后价值。
Eur J Prev Cardiol. 2021 Apr 10;28(2):235–242. doi: 10.1177/2047487319853343.
8
Effects of Testosterone Deficiency and Angiotensin II-Induced Hypertension on the Biomechanics of Intramural Coronary Arteries.睾酮缺乏与血管紧张素II诱导的高血压对壁内冠状动脉生物力学的影响。
J Sex Med. 2020 Dec;17(12):2322-2330. doi: 10.1016/j.jsxm.2020.09.003. Epub 2020 Oct 14.
9
Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study.性激素与男性和绝经后女性心力衰竭事件:社区动脉粥样硬化风险研究。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):e3798-807. doi: 10.1210/clinem/dgaa500.
10
A guide for Gensini Score calculation.Gensini评分计算指南。
Atherosclerosis. 2019 Aug;287:181-183. doi: 10.1016/j.atherosclerosis.2019.05.012. Epub 2019 May 10.